Purchasing evidence: the corollary of evidence-based purchasing.

Purchasing Power Parity Hypothesis In OIC Countries: Evidence From Panel Unit Root Tests With Heterogeneous Structural Breaks

Does Scale of Public Hospitals Affect Bargaining Power? Evidence From Japan

Background Many of public hospitals in Japan have had a deficit for a long time. Japanese local governments have been encouraging public hospitals to use group purchasing of drugs to benefit from the economies of scale, and increase their bargaining power for obtaining discounts in drug purchasing, thus improving their financial situation. In this study, we empirically investigate whether or no...

Should Indians Pay more for Renewable Energy Based Electricity? - The Need for Evidence Based Consumer Tariffs for Electricity in India

India seeks to achieve 175 Giga-Watt (GW) of Renewable power by 2022. As of December 2017, out of 333 GW of total installed capacity of electricity, close to 62GW come from renewable sources. Meeting the set targets calls for augmentation of renewable energy based capacities as expeditiously as possible. However, the sick financial health of the distribution companies/utilities, who act a...

A hybrid approach to supplier performance evaluation using artificial neural network: a case study in automobile industry

For many years, purchasing and supplier performance evaluation have been discussed in both academic and industrial circles to improve buyer-supplier relationship. In this study, a novel model is presented to evaluate supplier performance according to different purchasing classes. In the proposed method, clustering analysis is applied to develop purchasing portfolio model using available data in...

Reflections on Norheim (2018), Disease Control Priorities Third Edition Is Published; Comment on “Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy”

The publication of Disease Control Priorities, 3rd edition (DCP3) is a major milestone in the global health world. DCP3 reviews and summarizes high quality health intervention effectiveness and cost-effectiveness evidence relevant to low- and middle-income countries and is freely available to users...